Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...
A breakthrough technique that can help measure the brain proteins that trigger Alzheimer's disease, could also lead to ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
NeoGenomics, Inc. recently showcased new assay data and highlighted its RaDaR ST molecular residual disease test at the European Society for Medical Oncology Congress 2025, presenting how this ...
Pneumonia remains one of the leading causes of death in low- and middle-income countries, where access to advanced medical ...
In an effort to support preventive cancer care, Burjeel Hospitals, has announced the launch of Trucheck™ intelli, an advanced ...
Pearsanta, a subsidiary of Aditxt, has commenced enrolment in a clinical trial to assess the blood-based Mitomic ...
MVZ HPH Institute for Pathology and Hematopathology GmbH, today announced the availability of HPH MRD, a new tumor-informed ...
The global Human Papilloma Virus/HPV Test and Pap Smear/Test Market, valued at US$2.29 billion in 2024, stood at US$2.44 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from ...